82 top medical experts on Renal Aminoacidurias across 9 countries and 1 U.S. states, including 2 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Renal Aminoacidurias: A group of inherited kidney disorders characterized by the abnormally elevated levels of amino acids in urine. Genetic mutations of transport proteins result in the defective reabsorption of free amino acids at the proximal renal tubules. Renal aminoaciduria are classified by the specific amino acid or acids involved.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Inborn Errors Renal Tubular Transport (984) and Narrower Categories: Cystinuria (643), Hartnup Disease (43).
  4. Synonyms: Renal Aminoaciduria


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Berthou, Christian    Google Publications
    Physician  Clinical Trial 
    Subjects: Antineoplastic Agents; Fanconi Syndrome; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines
    Categories: Adverse Effects; Chemically Induced; Drug Therapy
    Imatinib mesylate induces massive and nonspecific aminoaciduria in CML patients. (2012)

  2. Tempescul, Adrian    Google Publications
    Physician  Clinical Trial 
    Subjects: Antineoplastic Agents; Fanconi Syndrome; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines
    Categories: Adverse Effects; Chemically Induced; Drug Therapy
    Imatinib mesylate induces massive and nonspecific aminoaciduria in CML patients. (2012)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);